GoKawiilY-shaped biomolecules called antibodies are scientific workhorse tools that researchers use to bind to and track specific proteins.Credit: Nemes Laszlo/Science Photo Library
Catalogue entries for more than 100 antibodies sold by the research services and supply company Thermo Fisher Scientific contain images that have apparently been manipulated, according to a pair of researchers who specialize in scientific integrity issues.
On 28 May, the researchers documented their findings online in a database that includes 127 “problematic images” associated with the company’s antibodies. Issues with the images — which are included in the catalogue to demonstrate antibodies’ quality and performance — range from minor alterations that make the images look nicer to extensive changes that raise questions of data soundness. The effort was led by Reese Richardson, a metascientist at Northwestern University in Evanston, Illinois.
How to spot suspicious papers: a sleuthing guide for scientists
Science sleuths have uncovered numerous manipulations in images from published scientific papers, but the latest discoveries are the first set of issues found in a vendor catalogue. Image alteration does not necessarily mean the underlying products are defective.
Antibodies — specialized Y-shaped biomolecules — are a crucial tool for researchers in the biological sciences, who use them in experiments to bind to and track specific proteins. But for decades, scientists have complained about the quality and performance of antibodies sourced from commercial suppliers, calling it a reliability crisis. A 2023 eLife survey1 of 614 commercial antibodies found that more than half of them did not work as specified.
“We take this matter seriously and have initiated a comprehensive internal review,” says Sandy Pound, the chief communications officer for Thermo Fisher, headquartered in Waltham, Massachusetts. “Moving forward, where an original image is not present or available, we will ensure that website users are informed that antibody images may have been optimized for presentation and clarity on the website.”
Since the sleuths posted their findings online, some researchers have been asking whether companies are not carefully validating their products and therefore contributing to the antibody reliability crisis. “I can’t help but feel that at some level this does potentially indicate some shortcomings of the reagents themselves,” says Jennifer Byrne, a cancer researcher at the University of Sydney in Australia.
Others, though, say there is probably no link. “My answer would be no,” says Carl Laflamme, lead scientist for Antibody Characterization through Open Science (YCharOS, pronounced ‘Icarus’), a programme that tests antibodies sold by commercial vendors, including Thermo Fisher. The antibody reliability crisis has existed for years and is not due to some apparently altered images on a company’s website, says Laflamme, who is a cell biologist at McGill University in Montreal, Canada.
A crisis of reliability
... continue reading